The Journal of Immunology, Vol 148, Issue 1 19-28, Copyright © 1992 by American Association of Immunologists

ARTICLES

Expression of variable exon A-, B-, and C-specific CD45 determinants on peripheral and thymic T cell populations

KS Hathcock, G Laszlo, HB Dickler, SO Sharrow, P Johnson, IS Trowbridge and RJ Hodes
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

A mAb (I/24) has been generated that is specific for a determinant on mouse CD45 molecules. Reactivity of this mAb with a panel of CD45 transfected cell lines demonstrated that the determinant recognized is dependent upon expression of one or more CD45 variable exons and that exon C is sufficient for its expression. The exon C-specific epitope detected by I/24 is expressed at high density on essentially all B lymphocytes and at an intermediate density on the vast majority of CD8+ splenic T cells. Two distinct subpopulations of CD4+ splenic T cells were detected, a minor subpopulation that expresses this exon determinant at high density and a major subpopulation that expresses it at a much lower density. This first identification of a CD45RC-specific reagent allowed a comparison of the expression of exon A-, exon B-, and exon C-specific determinants on peripheral and thymic lymphoid populations. When splenic lymphocytes were analyzed for expression of CD45RA (reactive with mAb 14.8), CD45RB (reactive with mAb 23G2 or mAb 16.A), and CD45RC (reactive with mAb I/24) determinants, it was found that each of these CD45 determinants had a distinct pattern of expression on CD4+ and CD8+ T cells and B cells. CD45RB and RC epitopes were also detected at high density on a small proportion (0.7 to 4.1%) of thymocytes. Both CD45RB and RC epitopes were found predominantly on CD4-CD8- and CD4-CD8+ thymocytes but were also found on small numbers of CD4+CD8+ and CD4+CD8- cells. The population of thymocytes that expressed CD45RB and CD45RC determinants displayed a novel TCR CD3 phenotype characterized by a level of expression that was intermediate between that seen in the larger CD3 bright and CD3 dull populations of thymocytes.

This article has been cited by other articles:

				R. Falahati and D. Leitenberg Changes in the Role of the CD45 Protein Tyrosine Phosphatase in Regulating Lck Tyrosine Phosphorylation during Thymic Development J. Immunol., February 15, 2007; 178(4): 2056 - 2064. [Abstract] [Full Text] [PDF]

				J. Dooley, M. Erickson, and A. G. Farr An Organized Medullary Epithelial Structure in the Normal Thymus Expresses Molecules of Respiratory Epithelium and Resembles the Epithelial Thymic Rudiment of Nude Mice J. Immunol., October 1, 2005; 175(7): 4331 - 4337. [Abstract] [Full Text] [PDF]

				A. Takeda, A. Matsuda, R. M. J. Paul, and N. R. Yaseen CD45-associated protein inhibits CD45 dimerization and up-regulates its protein tyrosine phosphatase activity Blood, May 1, 2004; 103(9): 3440 - 3447. [Abstract] [Full Text] [PDF]

				S. Ogilvy, C. Louis-Dit-Sully, J. Cooper, R. L. Cassady, D. R. Alexander, and N. Holmes Either of the CD45RB and CD45RO Isoforms Are Effective in Restoring T Cell, But Not B Cell, Development and Function in CD45-Null Mice J. Immunol., August 15, 2003; 171(4): 1792 - 1800. [Abstract] [Full Text] [PDF]

				Z. GAO, R. ZHONG, J. JIANG, B. GARCIA, J. J. XING, M. J. WHITE, and A. I. LAZAROVITS Adoptively Transferable Tolerance Induced by CD45RB Monoclonal Antibody J. Am. Soc. Nephrol., February 1, 1999; 10(2): 374 - 381. [Abstract] [Full Text]

				C. S. Freitas, S. R. Dalmau, and W. Savino Epidermal Growth Factor (EGF) Modulates Fetal Thymocyte Growth and Differentiation: Partial Reversal by Insulin, Mimicking by Specific Inhibitors of EGF Receptor Tyrosine Kinase Activity, and Differential Expression of CD45 Phosphatase Isotypes J. Immunol., October 1, 1998; 161(7): 3384 - 3392. [Abstract] [Full Text] [PDF]

				G. P. Basadonna, L. Auersvald, C. Q. Khuong, X. X. Zheng, N. Kashio, D. Zekzer, M. Minozzo, H.-Y. Qian, L. Visser, A. Diepstra, et al. Antibody-mediated targeting of CD45 isoforms: A novel immunotherapeutic strategy PNAS, March 31, 1998; 95(7): 3821 - 3826. [Abstract] [Full Text] [PDF]

				M. Krishna and A. Varki 9-O-Acetylation of Sialomucins: A Novel Marker of Murine CD4 T Cells that Is Regulated during Maturation and Activation J. Exp. Med., June 2, 1997; 185(11): 1997 - 2013. [Abstract] [Full Text] [PDF]